← Back to headlines
Neuropace Targets $99M-$101M Revenue by 2026
Neuropace has provided a revenue outlook of $99 million to $101 million for 2026, aiming for 21%-23% underlying RNS growth.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
